INSIDE INDUSTRY.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      INDEX Ventures (Company) ; ENZO Biochem Inc. 081664328 ENZ; PFIZER Inc. 001326495 PFE; IQVIA Holdings Inc. 073631694 RX
    • Abstract:
      Simulations Plus Announces Preliminary Success in Malaria Drug Design Project. xCELLigence System Evaluated in EU Project to Replace Animal Experiments in Cosmetics Industry. Progress in $100 Million Biodiesel and Commercial Fish Food Project. QIAGEN and Bio-X Center Open Shanghai Translational Medicine Lab. Index Ventures Launches First 150m Life Sciences Fund. Enzo Biochem Expands Distribution with Japan's Cosmo Bio. Maxwell Biotech Venture Fund Invests in Hepatitis B/D. ScinoPharm and NHRI Announce Jointly Developed Diabetes Drug. Calibr: A New Paradigm for Academic - Industry Cooperation. Biocon and Pfizer End Commercialization Agreement. Plandai Biotech Demonstrates Significance of Flavonoid & Polyphenol Bioavailability. Ceva Uses ProBioGen's AGE1.CR Cell Line for Viral Vaccine Production. Quintiles to Sign Memorandum of Agreement with Malaysia Biotechnology Corporation. [ABSTRACT FROM AUTHOR]
    • Abstract:
      Copyright of Asia Pacific Biotech News is the property of World Scientific Publishing Company and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)